Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma, The Journal of Experimental Medicine, vol.81, issue.6, pp.851-862, 2003. ,
DOI : 10.1084/jem.20022089
The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma, Blood, vol.102, issue.12, pp.3871-3879, 2003. ,
DOI : 10.1182/blood-2003-06-1841
Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?, Blood, vol.125, issue.1, pp.33-39, 2015. ,
DOI : 10.1182/blood-2014-05-575092
The molecular pathogenesis of primary mediastinal large B-cell lymphoma, Blood, vol.118, issue.10, pp.2659-2669, 2011. ,
DOI : 10.1182/blood-2011-05-326538
Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma, Nature Genetics, vol.362, issue.4, pp.329-335, 2014. ,
DOI : 10.1038/ng.2900
Activating mutations affecting the NF-kappa B pathway and EZH2-mediated epigenetic regulation are rare events in primary mediastinal large B-cell lymphoma, Anticancer research, vol.34, pp.5503-5507, 2014. ,
Whole exome sequencing of relapsed/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma, Genes, Chromosomes and Cancer, vol.110, issue.3, 2015. ,
DOI : 10.1002/gcc.22328
URL : https://hal.archives-ouvertes.fr/hal-01237083
Next Generation Sequencing in Diffuse Large B Cell Lymphoma Highlights Molecular Divergence and Therapeutic Opportunities: a LYSA Study. Clinical cancer research : an official journal of the, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01442496
SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients, Leukemia, vol.98, issue.1, pp.108-117, 2014. ,
DOI : 10.1038/leu.2013.263
Genomic and molecular characterization of esophageal squamous cell carcinoma Cryptic XPO1-MLLT10 translocation is associated with HOXA locus deregulation in T-ALL, Nature genetics Blood, vol.46124, issue.11, pp.467-4733023, 2014. ,
KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-cell acute lymphoblastic leukaemia and acute myeloid leukaemia Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia, British journal of haematology Blood, vol.161120, issue.13, pp.117-1274621, 2012. ,
Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial, The Lancet Oncology, vol.12, issue.5, pp.460-468, 2011. ,
DOI : 10.1016/S1470-2045(11)70069-9
Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial, The Lancet, vol.378, issue.9806, pp.1858-1867, 2011. ,
DOI : 10.1016/S0140-6736(11)61040-4
Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial, The Lancet Oncology, vol.14, issue.6, pp.525-533, 2013. ,
DOI : 10.1016/S1470-2045(13)70122-0
Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA, Haematologica, vol.96, issue.8, pp.1136-1143, 2011. ,
DOI : 10.3324/haematol.2010.038109
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B) Annals of oncology : official journal of the European Society for Medical Oncology Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma, ESMO The American journal of surgical pathology, vol.2429, pp.1032-10371411, 2005. ,
MedB-1, a human tumor cell line derived from a primary mediastinal large B-cell lymphoma, International Journal of Cancer, vol.75, issue.3, pp.348-353, 2001. ,
DOI : 10.1002/ijc.1211
B-cell non-Hodgkin's lymphoma cell line (Karpas 1106) with complex translocation involving 18q21.3 but lacking BCL2 rearrangement and expression, Blood, vol.84, pp.3422-3428, 1994. ,
U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma, International Journal of Cancer, vol.30, issue.Suppl 1, pp.555-5631, 2006. ,
DOI : 10.1002/ijc.21417
Rgb: a scriptable genome browser for R, Bioinformatics, vol.30, issue.15, pp.2204-2205, 2014. ,
DOI : 10.1093/bioinformatics/btu185
Jetset: selecting the optimal microarray probe set to represent a gene limma powers differential expression analyses for RNAsequencing and microarray studies Nucleic acids research 2015 A chemical genetic screen identifies inhibitors of regulated nuclear export of a Forkhead transcription factor in PTEN-deficient tumor cells Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group, BMC bioinformatics Cancer cell Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol.12417, issue.28, pp.474-26463, 1999. ,
Structural basis for leucine-rich nuclear export signal recognition by CRM1 Evaluation of structural and evolutionary contributions to deleterious mutation prediction A general framework for estimating the relative pathogenicity of human genetic variants, Nature Journal of molecular biology Nature genetics, vol.45832246, issue.30, pp.1136-1141891, 2002. ,
Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene, Blood, vol.87, pp.1571-1578, 1996. ,
Gains ofREL in primary mediastinal B-cell lymphoma coincide with nuclear accumulation of REL protein, Genes, Chromosomes and Cancer, vol.82, issue.4, pp.406-415, 2007. ,
DOI : 10.1002/gcc.20420
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways, Proceedings of the National Academy of Sciences, vol.105, issue.36, pp.13520-13525, 2008. ,
DOI : 10.1073/pnas.0804295105
Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells, Blood, vol.125, issue.7, pp.1061-1072, 2015. ,
DOI : 10.1182/blood-2014-11-610436
B-aggressive Lymphoma Family Proteins Have Unique Domains That Modulate Transcription and Exhibit Poly(ADP-ribose) Polymerase Activity, Journal of Biological Chemistry, vol.280, issue.40, pp.33756-33765, 2005. ,
DOI : 10.1074/jbc.M505408200
CRM1 as a new therapeutic target for non-Hodgkin lymphoma, Leukemia Research, vol.39, issue.1, pp.38-46, 2015. ,
DOI : 10.1016/j.leukres.2014.10.003
CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications, Leukemia, vol.69, issue.1, pp.155-165, 2014. ,
DOI : 10.1038/leu.2013.115
Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation, Oncogene, vol.28, issue.18, pp.2679-2684, 2006. ,
DOI : 10.1038/sj.onc.1209151
Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma, Blood, vol.114, issue.6, pp.1236-1242, 2009. ,
DOI : 10.1182/blood-2009-03-209759
URL : https://hal.archives-ouvertes.fr/inserm-00411059
Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma? Current hematologic malignancy reports 2012 Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?, Blood, vol.7125, issue.42, pp.241-24733, 2015. ,
NF??B activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes, Blood, vol.106, issue.4, pp.1392-1399, 2005. ,
DOI : 10.1182/blood-2004-12-4901
Identification of Primary Mediastinal Large B-cell Lymphoma at Nonmediastinal Sites by Gene Expression Profiling, The American Journal of Surgical Pathology, vol.39, issue.10, pp.1322-1330, 2015. ,
DOI : 10.1097/PAS.0000000000000473
Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line Nucleocytoplasmic shuttling by nucleoporins Nup153 and Nup214 and CRM1-dependent nuclear export control the subcellular distribution of latent Stat1, Blood The Journal of cell biology, vol.105165, issue.46, pp.2535-2542823, 2004. ,
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers, Nature, vol.100, issue.7338, pp.377-381, 2011. ,
DOI : 10.1038/nature09754
FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma, Oncotarget, vol.5, issue.14, pp.5392-5402, 2014. ,
DOI : 10.18632/oncotarget.2107
Targeting the nuclear transport machinery by rational drug design The GTP-binding domain of class II transactivator regulates its nuclear export, Current pharmaceutical design J Immunol, vol.19170, issue.50, pp.2318-2325922, 2003. ,
Understanding XPO1 Target Networks Using Systems Biology and Mathematical Modeling, Current Pharmaceutical Design, vol.20, issue.1, pp.56-65, 2014. ,
DOI : 10.2174/13816128113199990611
URL : http://doi.org/10.2174/13816128113199990611
Identification of nucleocytoplasmic cycling as a remote sensor in cellular signaling by databased modeling Identifying drug-target selectivity of smallmolecule CRM1/XPO1 inhibitors by CRISPR/Cas9 genome editing Nucleo-cytoplasmic transport as a therapeutic target of cancer Induction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma, Proceedings of the National Academy of Sciences of the United States of America Chemistry & biology Journal of hematology & oncology Cancer Sci, vol.100227105, issue.55, pp.1028-1033, 2003. ,